Skip to content

Clinical trials

Recruiting Amyotrophic Lateral Sclerosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Status: Recruiting Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20211
20231
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Third Hospital2
Dongzhimen Hospital, Beijing1
First Affiliated Hospital of Fujian Medical University1
First People's Hospital of Hangzhou1
Hong Chen1
Novabio Therapeutics1
Ractigen Therapeutics.1
Shanghai StairMed Technology Co., Ltd.1
Shanghai Zhimeng Biopharma, Inc.1
Talengen Institute of Life Sciences, Shenzhen, P.R. China.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis13
Neurodegenerative Diseases2
Brain Stem Infarctions1
Frailty1
Inflammation1
Motor Neuron Disease1
Quadriplegia1
Spinal Cord Injuries1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.